期刊文献+

中国人体器官获取组织发展与建设历程 被引量:21

Development and history of organ procurement organization in China
原文传递
导出
摘要 器官移植技术自20世纪70年代在我国开展以来,已成为治疗终末期器官功能衰竭的唯一有效手段。自21世纪以来推行公民逝世后自愿器官捐献重大改革,保障了我国器官移植事业健康发展。建立科学规范的器官获取组织,是保证我国器官移植快速发展的基石。器官捐献受我国传统文化、伦理、法制、经济、社会等诸多因素的影响,体系的建立艰难曲折。在党中央、国务院坚强支持下,在国家卫健委和中国红十字总会的直接领导下,经过十余年艰辛改革,我国已初步建立了一套公平、公正、阳光、透明的公民器官捐献移植体系。回顾我国器官获取组织的发展历程,探索符合中国国情的器官捐献和移植的"中国模式",助力我国器官移植事业有序规范发展。 Organ transplantation has been the only effective method for the treatment of end-stage organ failure since its inception in China in the 1970 s. Since the 21 st century, an important reform of voluntary organ donation after the death of citizens has been carried out, which has guaranteed the healthy development of organ transplantation in China. The establishment of a scientific and standard organ procurement organization is the foundation stone of the rapid development of organ transplantation in China. Organ donation is affected by many factors such as traditional culture,ethics, legal system, economy, and society, and the establishment of the system is difficult. With the strong support of the State Council of China, the National Health Commission, and the Chinese Red Cross Society, China has initially established a fair, just, and transparent system for citizen organ donation and transplantation. Reviewing the development of organ procurement organization in China will be beneficial to explore the "Chinese model" of organ donation and transplantation, and promote standardizing and regularizing development of organ transplantation.
作者 黄伟 叶啟发 范晓礼 邹永康 杜冰 马旭东 HUANG Wei;YE Qifa;FAN Xiaoli;ZOU Yongkang;DU Bing;MA Xudong(Zhonnan Hospital of Wuhan University,Institute of Hep a to biliary Diseases of Wuhan University,Transp/ant Center of Wuhan Udiversity,&Hubei Key Laboratory of Medical Technology on Transplantation,Wuhan 430071,Hubei,China;The 3rd Xiangya Hospital of Central South University&Research Center of National Health Ministry on Transplantation Medicine Engineering and Technology,Chungshu 410013,Hunan,China;National Health Commission of the People's Republic of China,Beijing 100044,China)
出处 《武汉大学学报(医学版)》 CAS 2021年第2期173-178,共6页 Medical Journal of Wuhan University
基金 武汉大学医学腾飞计划——“转化医学、医学+医学平台建设项目”(临床医学)(编号:TFLC2018003) 武汉大学中南医院科技创新培育基金药护技和管理专项基金项目(编号:znpy2019098)。
关键词 器官移植 器官获取组织 器官捐献 Organ Transplantation Organ Procurement Organization Organ Donation
  • 相关文献

参考文献18

二级参考文献94

  • 1中国人体器官捐献试点工作方案[J].实用器官移植电子杂志,2013,1(5):265-270. 被引量:5
  • 2刘晓惠.器官移植中供体的民事法律保护[J].中国卫生法制,2006,14(2):26-28. 被引量:11
  • 3张水军,翟文龙,宋燕,史冀华,李震,李捷,陈实.脑死亡状态对巴马小型猪肝脏形态与功能的影响[J].中华医学杂志,2006,86(18):1244-1248. 被引量:4
  • 4潘映辐.脑死亡确诊与诱发电位进展[J].中华医学杂志,2006,86(23):1649-1653. 被引量:4
  • 5Matas AJ, Bartlett ST, Leichtman AB, et al. Morbidity and mortality after living kidney donation, 1999-2001: survey of United States transplant centers. Am J Transplant, 2003,3: 830-834.
  • 6Hobson JE. How the system functions. The roles of the United Network of Organ Sharing, the organ procurement and transplantation network, and the organ procurement organization in heart transplantation. Crit Care Nurs Clin North Am,2000, 12: 11-21.
  • 7Rosendale JD, Chabalewski FL, McBride MA, et al. Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant, 2002,2:761-768.
  • 8Saas P, Kleinclauss F, Tiberghien P. Immune regulation and transplantation: an exciting challenge. Transplantation, 2004, 77(1 Suppl): S38-S40.
  • 9Schnitzler MA, Craig KE, Hardinger KE, et al. Mycophenolate mofetil is associated with less death with function than azathioprine in cadaveric renal transplantation. Nephrol Dial Transplant, 2003,18:1197-1200.
  • 10Pietra BA. Transplantation immunology 2003: simplified approach. Pediatr Clin North Am, 2003,50: 1233-1259.

共引文献309

同被引文献239

引证文献21

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部